CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 47 filers reported holding CATALYST BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $140,000 | +169.2% | 78,622 | 0.0% | 0.06% | +346.2% |
| Q1 2022 | $52,000 | -27.8% | 78,622 | 0.0% | 0.01% | -18.8% |
| Q4 2021 | $72,000 | -77.7% | 78,622 | 0.0% | 0.02% | -77.8% |
| Q3 2021 | $323,000 | -5.0% | 78,622 | 0.0% | 0.07% | +44.0% |
| Q2 2021 | $340,000 | -14.1% | 78,622 | 0.0% | 0.05% | -19.4% |
| Q1 2021 | $396,000 | -20.2% | 78,622 | 0.0% | 0.06% | -51.9% |
| Q4 2020 | $496,000 | +46.7% | 78,622 | 0.0% | 0.13% | -28.3% |
| Q3 2020 | $338,000 | -26.8% | 78,622 | 0.0% | 0.18% | -20.7% |
| Q2 2020 | $462,000 | +34.3% | 78,622 | 0.0% | 0.23% | +2.7% |
| Q1 2020 | $344,000 | -35.7% | 78,622 | 0.0% | 0.22% | -11.6% |
| Q4 2019 | $535,000 | +38.6% | 78,622 | 0.0% | 0.25% | +4.2% |
| Q3 2019 | $386,000 | -33.3% | 78,622 | 0.0% | 0.24% | -28.1% |
| Q2 2019 | $579,000 | – | 78,622 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 202,281 | $2,759,000 | 1.56% |
| ACUTA CAPITAL PARTNERS, LLC | 450,000 | $6,138,000 | 1.16% |
| NEXTHERA CAPITAL LP | 311,175 | $4,244,000 | 0.78% |
| Avoro Capital Advisors LLC | 400,000 | $5,456,000 | 0.35% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $818,000 | 0.34% |
| B. Riley Wealth Advisors, Inc. | 62,500 | $853,000 | 0.12% |
| Kalos Management, Inc. | 12,100 | $222,000 | 0.10% |
| J. Goldman & Co LP | 124,500 | $1,698,000 | 0.09% |
| ARDSLEY ADVISORY PARTNERS LP | 15,000 | $205,000 | 0.02% |
| DRW Securities, LLC | 12,000 | $164,000 | 0.02% |